AlphAIalphai — Financial news for AI agents
tickerreport.comJUN 43 min read$VEEVNeutralMed

Veeva Systems (NYSE:VEEV) Price Target Cut to $220.00 by Analysts at Canaccord Genuity Group

Canaccord Genuity Group cut its Veeva Systems (NYSE:VEEV) price target to $220 from $235 and kept a “hold” rating, according to a Thursday research note cited by Benzinga. The target implies 23.27% upside. Veeva shares were $178.46 midday. The article also notes Q1 EPS of $2.24 vs $2.14 expected and revenue of $882.95M vs $857.73M.

AI DeskJune 4, 2026
Source · tickerreport.com
AI analysis
Actionability
Med
Sentiment · $VEEV
Neutral
Timing
after-hours/next-session positioning following the research note and target cut
Market alignment
mixed—earnings/guidance supportive, but target reductions and Hold ratings add caution
Why this matters for $VEEV

Sell-side target reset (Hold) after a strong earnings print and guidance lift, likely sustaining near-term valuation/expectations debate.

Relevance context

Canaccord cut Veeva’s price target from $235 to $220 and kept a Hold rating, adding fresh sell-side pressure despite the recent earnings beat.

Price-impact prediction

Choppy-to-soft bias near term; downside risk if more firms follow with lower targets or downgrades.

Background

Veeva recently reported quarterly results (June 3) with EPS and revenue above consensus and provided FY2027/Q2 2027 guidance.

Why it matters

This piece updates the sell-side stance via a specific price-target reduction (Canaccord) while reiterating that the company’s fundamentals were strong, creating a mixed setup for near-term trading.

Market relevance

A targeted analyst downgrade in price expectations arrives right after a beat-and-raise quarter, supporting range-bound trading unless additional estimate changes emerge.

Market effects

Sector

Signals that life-sciences cloud/software names may be trading on valuation and execution expectations, not just quarterly beats.

Regional

Primarily US large-cap software sentiment; limited direct regional spillover beyond healthcare IT.

Global

Low—research target revisions are company-specific and not tied to global macro or regulation.

Alternative perspectives

Contrarian view

The earnings beat and guidance lift may outweigh target cuts; the stock could absorb downgrades if execution momentum persists.

Overlooked factors

The article cites insider selling (director) and multiple target trims; traders may want to watch whether these are isolated or part of a broader estimate reset.

Key entities

  • company
    Veeva Systems

    Cloud software provider for life sciences; subject of the price-target cut and recent earnings/guidance details.

  • analyst_firm
    Canaccord Genuity Group

    Reduced Veeva’s target price to $220 and maintained a Hold rating.

Read at source← All news

Related articles

JUN 4
$AVGOMed

S&P Futures Muted as Fresh U.S.-Iran Hostilities Lift Oil and Bond Yields, ADP Jobs Report and Broadcom Earnings on Tap

S&P 500 futures were muted as U.S. JOLTS job openings rose to 7.618M in April, above expectations, while oil and bond yields moved higher amid fresh U.S.-Iran tensions. Cleveland Fed President Beth Hammack said rates should stay unchanged for now. Investors awaited ADP jobs, ISM services, factory orders, and EIA crude inventories; 10-year Treasury yield was 4.49%.

finance.yahoo.com4 min
JUN 4
$VEEVMed

Veeva (VEEV) Q1 2027 Earnings Call Transcript

Veeva reported fiscal Q1 2027 revenue of $883 million and non-GAAP operating income of $395 million, both above internal guidance, according to management. Professional services hit a record quarter, driven by R&D and consulting. Commercial subscription guidance rose $15 million for the year, including $10 million from the Ostro acquisition. Veeva also discussed early rollout of AI “Falcon” and ongoing Vault CRM migrations.

fool.com10 min
MAY 31
$VEEVLow

Veeva Systems (VEEV) Announces that Kindeva is Adopting Veeva Quality Cloud

The article says Kindeva is adopting Veeva Quality Cloud, according to Veeva Systems. It provides broader commentary on generative AI’s potential and cites remarks by figures including Jeff Bezos, Andy Jassy, and Elon Musk. It also promotes a newsletter subscription with claims about past stock performance and “upside” targets, but no specific Veeva financial figures are given.

insidermonkey.com3 min
MAY 30
$VEEVMed

10 Best SaaS Stocks to Buy According to Hedge Funds

The article says SaaS stocks fell in 2026 amid AI disruption fears, citing IBM’s 10.3% drop and ServiceNow’s nearly 15% drop on April 23 despite Q1 revenue/profit beats and ServiceNow’s Middle East deal delays. It notes a May 19 rebound in Workday, ServiceNow and Salesforce. Using Insider Monkey Q1 2026 data, it lists Veeva (62 funds, $2.95B) and Autodesk (67 funds, $3.17B), including Autodesk’s $3.6B MaintainX deal and raised FY27 guidance.

insidermonkey.com7 min